← Leaderboards
Ashley T. Haase
Northwestern University
$31,817,297
Attributed
$33,288,358
Total exposure
31
Grants
23
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$33,288,358 · 31
By mechanism
R01$15,300,038 · 6
U19$3,965,117 · 2
R37$3,259,010 · 1
P01$3,164,370 · 2
P51$2,661,584 · 14
R33$2,350,837 · 1
Top collaborators
- David Masopust4 shared
Most similar at Northwestern University
Same institution · by research overlap
- Karla Fullner Satchell$37,906,316
- Sally M McFall$6,867,009
- Robert O Bonow$1,979,188
- Charles David Pauza$11,027,875
- Robert A Linsenmeier$5,310,746
Others in their field
Top investigators on “In Situ Hybridization”
- Hongkui Zeng · Allen Institute$59,560,025
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$37,153,410
- Daniel H Geschwind · University Of California Los Angeles$35,449,972
- Ed Lein · Allen Institute$31,650,014
- Marianne Bronner-Fraser · California Institute Of Technology$31,015,199
Research focus
In Situ HybridizationInfectionCellsTissuesHiv InfectionsVirusMacaca MulattaHiv-1PreventViralLymphoid TissueTransmission ProcessIn VivoCd4 Positive T LymphocytesVaginaWomanIn SituNonhuman PrimateDesignResearch PersonnelTechnologyGene ExpressionT-LymphocyteCervical
Grant awards (84)
A New Approach to Reactivating HIV from Latency$599,565
R01 · FY2021 · AI · contact PI
A New Approach to Reactivating HIV from Latency$600,421
R01 · FY2020 · AI · contact PI
A New Approach to Reactivating HIV from Latency$606,464
R01 · FY2019 · AI · contact PI
Direct Approach to Identifying Sources of Rebound in Lymphatic Tissue after Treatment Interruption$231,000
R21 · FY2019 · AI · contact PI
A New Approach to Reactivating HIV from Latency$516,862
R01 · FY2018 · AI · contact PI
Direct Approach to Identifying Sources of Rebound in Lymphatic Tissue after Treatment Interruption$191,875
R21 · FY2018 · AI · contact PI
A New Approach to Reactivating HIV from Latency$527,939
R01 · FY2017 · AI · contact PI
Vaccine Design to Concentrate Protective Antibodies at the Mucosal Border$747,607
R01 · FY2015 · AI · contact PI
Pathology$496,287
U19 · FY2015 · AI · contact PI
In Situ Hybridization and Immunohistochemistry Core$247,944
U19 · FY2015 · AI · contact PI
Vaccine Design to Concentrate Protective Antibodies at the Mucosal Border$750,260
R01 · FY2014 · AI · contact PI
Pathology$514,388
U19 · FY2014 · AI · contact PI
In Situ Hybridization and Immunohistochemistry Core$217,458
U19 · FY2014 · AI · contact PI
Vaccine Design to Concentrate Protective Antibodies at the Mucosal Border$750,808
R01 · FY2013 · AI · contact PI
Pathology$698,048
U19 · FY2013 · AI · contact PI
Impact of Extraordinarily Large Numbers of SIV-specific CD8 T Cells on Vaginal Tr$672,484
R01 · FY2013 · AI
In Situ Hybridization and Immunohistochemistry Core$251,115
U19 · FY2013 · AI · contact PI
Vaccine Design to Concentrate Protective Antibodies at the Mucosal Border$843,856
R01 · FY2012 · AI · contact PI
Impact of Extraordinarily Large Numbers of SIV-specific CD8 T Cells on Vaginal Tr$736,366
R01 · FY2012 · AI
Pathology$501,567
U19 · FY2012 · AI · contact PI
In Situ Hybridization and Immunohistochemistry Core$255,138
U19 · FY2012 · AI · contact PI
Tissue & Cellular Localization of Cryptic Replication$253,059
P01 · FY2012 · AI · contact PI
Impact of Extraordinarily Large Numbers of SIV-specific CD8 T Cells on Vaginal Tr$752,108
R01 · FY2011 · AI
Pathology$509,675
U19 · FY2011 · AI · contact PI
Tissue & Cellular Localization of Cryptic Replication$304,770
P01 · FY2011 · AI · contact PI
In Situ Hybridization and Immunohistochemistry Core$273,497
U19 · FY2011 · AI · contact PI
TOPICAL MICROBICIDE AGAINST SIV AND CHLAMYDIA$198,971
P51 · FY2011 · RR · contact PI
Microarray Studies to Discover Novel Host Defenses in SIV Infection$186,863
R21 · FY2011 · AI · contact PI
Impact of Extraordinarily Large Numbers of SIV-specific CD8 T Cells on Vaginal Tr$781,164
R01 · FY2010 · AI
Topical Microbicide Against SIV and Chlamydia$444,405
R33 · FY2010 · AI · contact PI
Microarray Studies to Discover Novel Host Defenses in SIV Infection$226,500
R21 · FY2010 · AI · contact PI
Tissue & Cellular Localization of Cryptic Replication$192,566
P01 · FY2010 · AI · contact PI
TOPICAL MICROBICIDE AGAINST SIV AND CHLAMYDIA$51,635
P51 · FY2010 · RR · contact PI
Topical Microbicide Against SIV and Chlamydia$1,443,416
R33 · FY2009 · AI · contact PI
TOPICAL MICROBICIDE AGAINST SIV AND CHLAMYDIA$196,590
P51 · FY2009 · RR · contact PI
SIV T CELLS IN VIVO$196,590
P51 · FY2009 · RR · contact PI
Tissue & Cellular Localization of Cryptic Replication$190,744
P01 · FY2009 · AI · contact PI
Functional Genomic Analysis of HIV-1 Infection in Lymphatic Tissues$575,172
R01 · FY2008 · AI · contact PI
In Situ Analysis of Immunity in Live Attenuated AIDS Vaccines$519,234
P01 · FY2008 · AI · contact PI
Topical Microbicide Against SIV and Chlamydia$463,016
R33 · FY2008 · AI · contact PI
PATHOGENESIS OF HIV INDUCED IMMUNODEFICIENCY$379,308
R37 · FY2008 · AI · contact PI
Tissue & Cellular Localization of Cryptic Replication$322,320
P01 · FY2008 · AI · contact PI
SIV T CELLS IN VIVO$163,829
P51 · FY2008 · RR · contact PI
PATHOGENESIS OF MUCOSAL TRANSMISSION/HIV ACUTE TRANSMISSION$163,829
P51 · FY2008 · RR · contact PI
TOPICAL MICROBICIDE AGAINST SIV AND CHLAMYDIA$163,829
P51 · FY2008 · RR · contact PI
Functional Genomic Analysis of HIV-1 Infection in Lymphatic Tissues$586,313
R01 · FY2007 · AI · contact PI
In Situ Analysis of Immunity in Live Attenuated AIDS Vaccines$524,564
P01 · FY2007 · AI · contact PI
PATHOGENESIS OF HIV INDUCED IMMUNODEFICIENCY$377,285
R37 · FY2007 · AI · contact PI
SIV T CELLS IN VIVO$214,423
P51 · FY2007 · RR · contact PI
PATHOGENESIS OF MUCOSAL TRANSMISSION/HIV ACUTE TRANSMISSION$211,927
P51 · FY2007 · RR · contact PI
Topical Microbicide Against SIV and Chlamydia$173,169
R21 · FY2007 · AI · contact PI
Functional Genomic Analysis of HIV-1 Infection in LTs$596,286
R01 · FY2006 · AI · contact PI
In Situ Analysis of Immunity in Live Attenuated AIDS Vaccines$470,721
P01 · FY2006 · AI · contact PI
PATHOGENESIS OF HIV INDUCED IMMUNODEFICIENCY$379,187
R37 · FY2006 · AI · contact PI
Topical Microbicide Against SIV and Chlamydia$216,932
R21 · FY2006 · AI · contact PI
PATHOGENESIS OF MUCOSAL TRANSMISSION/HIV ACUTE TRANSMISSION$163,288
P51 · FY2006 · RR · contact PI
SIV T CELLS IN VIVO$163,288
P51 · FY2006 · RR · contact PI
Functional Genomic Analysis of HIV-1 Infection in LTs$608,863
R01 · FY2005 · AI
In Situ Analysis of Immunity in Live Attenuated AIDS Vaccines$386,392
P01 · FY2005 · AI
PATHOGENESIS OF HIV INDUCED IMMUNODEFICIENCY$379,002
R37 · FY2005 · AI
SIV T CELLS IN VIVO$45,973
P51 · FY2005 · RR
PATHOGENESIS OF MUCOSAL TRANSMISSION/HIV ACUTE TRANSMISSION$45,973
P51 · FY2005 · RR
Functional Genomic Analysis of HIV-1 Infection in LTs$609,139
R01 · FY2004 · AI
PATHOGENESIS OF HIV INDUCED IMMUNODEFICIENCY$369,963
R37 · FY2004 · AI
MOLECULAR MECHANISMS OF INFECTIOUS DISEASE TRAINING$257,424
T32 · FY2004 · AI
PATHOGENESIS OF MUCOSAL TRANSMISSION/ACUTE SIV INFECTION$229,721
P51 · FY2004 · RR
SIV T CELLS IN VIVO$225,859
P51 · FY2004 · RR
PATHOGENESIS OF MUCOSAL TRANSMISSION/HIV TRANSMISSION$225,859
P51 · FY2004 · RR
PATHOGENESIS OF MUCOSAL TRANSMISSION/ACUTE SIV INFECTION$782,176
R01 · FY2003 · AI
PATHOGENESIS OF HIV INDUCED IMMUNODEFICIENCY$356,837
R37 · FY2003 · AI
MOLECULAR MECHANISMS OF INFECTIOUS DISEASE TRAINING$254,390
T32 · FY2003 · AI
PATHOGENESIS OF MUCOSAL TRANSMISSION/ACUTE SIV INFECTION$897,733
R01 · FY2002 · AI
PATHOGENESIS OF HIV INDUCED IMMUNODEFICIENCY$347,817
R37 · FY2002 · AI
MOLECULAR MECHANISMS OF INFECTIOUS DISEASE TRAINING$234,740
T32 · FY2002 · AI
CORE--QUANTITATIVE IMAGING$0
P30 · FY2002 · CA
PATHOGENESIS OF MUCOSAL TRANSMISSION/ACUTE SIV INFECTION$742,747
R01 · FY2001 · AI
PATHOGENESIS OF HIV INDUCED IMMUNODEFICIENCY$339,057
R37 · FY2001 · AI
MOLECULAR MECHANISMS OF INFECTIOUS DISEASE TRAINING$254,931
T32 · FY2001 · AI
CORE--QUANTITATIVE IMAGING$0
P30 · FY2001 · CA
PATHOGENESIS OF MUCOSAL TRANSMISSION/ACUTE SIV INFECTION$755,940
R01 · FY2000 · AI
PATHOGENESIS OF HIV INDUCED IMMUNODEFICIENCY$330,554
R37 · FY2000 · AI
TRANS &PATHOG OF KS-ASSOCIATED HERPESVIRUS INFECTION$259,765
R01 · FY2000 · CA
MOLECULAR MECHANISMS OF INFECTIOUS DISEASE TRAINING$186,328
T32 · FY2000 · AI
CORE--QUANTITATIVE IMAGING$173,250
P30 · FY2000 · CA